Fintel reports that on May 26, 2026, Barclays upgraded their outlook for agilon health (NYSE:AGL) from Underweight to Equal-Weight.
Analyst Price Forecast Suggests 65.02% Downside
As of May 14, 2026, the average one-year price target for agilon health is $30.22/share. The forecasts range from a low of $6.31 to a high of $75.60. The average price target represents a decrease of 65.02% from its latest reported closing price of $86.39 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for agilon health is 7,598MM, an increase of 30.54%. The projected annual non-GAAP EPS is 1.14.
What is the Fund Sentiment?
There are 18 funds or institutions reporting positions in agilon health. This is an decrease of 308 owner(s) or 94.48% in the last quarter. Average portfolio weight of all funds dedicated to AGL is 0.06%, an increase of 43.48%. Total shares owned by institutions decreased in the last three months by 95.42% to 20,100K shares. 
The put/call ratio of AGL is 0.10, indicating a bullish outlook.
What are Other Shareholders Doing?
Two Sigma Advisers holds 1,114K shares representing 6.68% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Rubicon Founders holds 252K shares representing 1.51% ownership of the company. In its prior filing, the firm reported owning 6,292K shares , representing a decrease of 2,400.01%. The firm decreased its portfolio allocation in AGL by 98.55% over the last quarter.
Counterpoint Mutual Funds holds 185K shares representing 1.11% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Wealth Enhancement Advisory Services holds 108K shares representing 0.65% ownership of the company. In its prior filing, the firm reported owning 324K shares , representing a decrease of 200.09%. The firm increased its portfolio allocation in AGL by 551.41% over the last quarter.
Hsbc Holdings holds 63K shares representing 0.38% ownership of the company. In its prior filing, the firm reported owning 63K shares , representing a decrease of 0.06%. The firm decreased its portfolio allocation in AGL by 61.69% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
